☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Grant
EMA to Grant Initial Authorization to Gilead's Remdesivir for COVID-19 is Imminent
May 18, 2020
Amgen and its Foundation Grant $12.5M to Support COVID-19 Relief Efforts Globally
March 24, 2020
PharmaMar's Lurbinectedin Granted as Orphan drug designation by U.S. FDA for Small Cell Lung Cancer(SCLC)
August 3, 2018
Load more...
Back to Home
